Long-term opioid therapy: Assessment of consequences and risks

Journal of Pain and Symptom Management

Volumn 11, Issue 5, 1996, Pages 274-286

  Savage, Seddon R ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

addict; addiction; alcoholism; dependency; ethics; Opioids; pain

Indexed keywords

OPIATE;

ARTICLE; DRUG USE; HUMAN; LAW; OPIATE ADDICTION; PAIN; PRESCRIPTION; RISK ASSESSMENT;

EID: 0029920390     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(95)00202-2     Document Type: Article

References (73)

1. Scott J. The white poppy: a history of opium. New York: Funk and Wagnalls, 1969.
2. Szasz T. Cures and control: panaceas and panapathogens. In: Friedman M, Zeese K, eds. On liberty and drugs. Washington, DC: The Drug Policy Foundation Press, 1992:1992.
3. Marks J, Sacher E. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973;78:173-181.
4. Shine D, Demas P. Knowledge of medical students, residents and attending physicians about opiate abuse. J Med Educ 1984;59:501-507.
5. Joranson D, Cleeland C, Weisman D. Opioids for chronic cancer and non-cancer pain: survey of medical licensing boards. Paper presented at the Tenth Annual Scientific Meeting of the American Pain Society in New Orleans, LA; 1991.
6. Clark H. Opioids, chronic pain, and the law. J Pain Symptom Manage 1993;8:297-306.
7. Jaffe J, Martin W. Opioid analgesics and antagonists. In: Gilman A, et al., eds. The pharmacologic basis of therapeutics. New York: Macmillan, 1980: 491-531.
8. Courtwright D. Dark paradise: opioid addiction in America before 1940. Cambridge, MA: Harvard University Press, 1982.
9. Joseph H, Appel P. Historical perspectives and public health issues. In: Panel C, ed. State methadone treatment guidelines. Rockville, MD: U.S. Department of Health and Human Services, 1991.
10. Brecher E. Licit and illicit drugs. In: Consumers union report on narcotics, stimulants, depressants, inhalants, hallucinogens, and marijuana. Boston, MA: Brown and Little, 1972.
11. Musto D. Historical perspectives on drug and alcohol abuse. In: Lowinson J, Ruiz P, Millman R, eds. Substance abuse: a comprehensive textbook. Baltimore: Williams and Wilkins, 1992.
12. Musto D. The American disease: origins of narcotic control. New York: Oxford University Press, 1987.
13. Morgan J. American opioidphobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse 1985;5:163.
14. Dole V, Nyswander M, Kreek M. Narcotic blockade. Arch Intern Med 1966;118:304-309.
15. Kreek M. Medical safety and side effects of methadone in tolerant individuals. JAMA 1973;223: 665-668.
16. Dole V, Joseph H. Longterm outcome of patients treated with methadone maintenance. Ann N Y Acad Sci 1978;311:181-189.
17. Ball J, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag, 1991.
18. Parrino M, ed. State methadone treatment guidelines. Treatment improvement protocol series. Rockville, MD: U.S. Department of Health and Human Services, 1991.
19. Parrino M. Overview: current treatment realities and future trends. In: Panel C, ed. State methadone treatment guidelines. Rockville, MD: U.S. Department of Health and Human Services, 1991:1-9.
20. Kennedy J, Crowley T. Chronic pain and substance abuse: a pilot study of opioid maintenance. J Subst Abuse Treat 1990;7:233-238.
21. Lowinson J, et al. Methadone maintenance. In: Lowinson J, Ruiz P, Millman R, eds. Substance abuse: a comprehensive text. Baltimore: Williams and Wilkens, 1992:550-561.
22. Kolb L. Types and characteristics of drug addicts. Mental Hygiene 1925;9:300.
23. Rayport M. Experience in the management of patients medically addicted to narcotics. JAMA 1954;165:684-691.
24. Portenoy RK Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990; 5(suppl):S46-S62.
25. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123.
26. Perry S, Heidrich G. Management of pain during debridement: a survey of U.S. burn units. Pain 1982;13:12-14.
27. Regier D, Meyers JK, Kramer M. The NIMH epidemiological catchment area study. Arch Gen Psychiatry 1984;41:934-958.
28. Vailliant GE. The natural history of alcoholism. Cambridge: Harvard University Press, 1983:1.
29. Robins L, Heltzer J, Prybeck T Alcohol disorders in the community: a report for the epidemiologic catchment area. In: Rose R, Barrett J, eds. Alcoholism: origins and outcomes. New York: Raven, 1987.
30. Lehman W, Barret M, Simpson D. Alcohol use by heroin addicts 12 years after drug abuse treatment. J Stud Alcohol 1990;51:233-244.
31. Secretary of the U.S. Department of Health and Human Services. Seventh special report to the U.S. Congress on alcohol and health. U.S. Department of Health and Human Services, 1990.
32. Acute Pain Management Guidelines Panel. Acute pain management: operative or medical procedures and trauma. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1992.
33. American Pain Society. Principles of analgesics use in the treatment of acute pain and chronic cancer pain, 2nd ed. Skokie, IL: American Pain Society, 1989.
34. Ready LB, Edwards WT, eds. Management of acute pain: a practical guide. Seattle, WA: International Association for the Study of Pain, 1992.
35. Schofferman J. Longterm use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993;8:279-288.
36. Schug S, Merry A, Acland R. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991;42:228-232.
37. Sees KL, Clark W. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993;8:257-264.
38. Zenz M, Strumph M, Tryba M. Long-term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992;7:69-77.
39. Jaffe J. Opiates: clinical aspects. In: Lowinson J, Ruiz P, Millman R, eds. Substance abuse: a comprehensive text. Baltimore: Williams and Wilkens, 1992:186-194.
40. Jaffe J. Drug addiction and drug abuse. In: Gilman A, et al, eds. The pharamacologic basis of therapeutics. New York: Macmillan, 1980:532-581.
41. Savage SR. Addiction in the treatment of pain: significance, recognition and treatment. J Pain Symptom Manage 1993;8:265-278.
42. Brodner RA, Taub A. Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: clinical syndrome and treatment. Mt. Sinai J Med 1978;45:233-237.
43. Blanchard EB, et al. The refractory headache patient 2: high medication rebound consumption (analgesic rebound) headache. Behav Res Ther 1989;27:411-420.
44. Kudrow L. Paradoxical effect of frequent analgesic use. Adv Neurol 1982;33:335-341.
45. Rapaport A. Analgesic rebound headache. Headache 1988;28:662-665.
46. Simon E. Opiates: neurobiology. In: Lowinson J, Ruiz P, Millman R, eds. Substance abuse: a comprehensive testbook. Baltimore: Williams and Wilkens, 1991:222-233.
47. Collin E, Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clinical Neuropharmacology 1991;14:465-488.
48. Hill H, et al. Self-administration of morphine in bone marrow transplant patients reduces drug treatment. Pain 1990;40:121-129.
49. Hill H, et al. Patient controlled analgesic infusions: alfentanyl versus morphine. Pain 1992;49: 301-310.
50. Foley K. Clinical tolerance to opioids. In: Basbaum A, Besson J, eds. Towards a new pharmacotherapy of pain. New York: John Wiley and Sons, 1991:181-203.
51. Twycross R. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol 1974;9:184-198.
52. Yaksh T. The spinal pharmacology of acutely and chronically administered opioids. J Pain Symptom Manage 1992;7:356-361.
53. Kissin I, Brown P, Bailey E. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology 1991;75:813-816.
54. Portenoy R. Pharmacotherapy of cancer pain. In: ICOR Courses, ed. Refresher courses on pain management. Adelaide, Australia, 1990:101-112.
55. Taylor CB, et al. The effects of detoxification, relaxation and brief supportive therapy on chronic pain. Pain 1980;8:319-329.
56. Finlayson RE, Maruta T, Morse BR. Substance dependence and chronic pain: profile of 50 patients treated in an alcohol and drug dependence unit. Pain 1986;26:167-174.
57. Finlayson RE, et al. Substance dependence and chronic pain: experience with treatment and follow-up results. Pain 1986;26:175-180.
58. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage 1994;9:462-473.
59. Turk DC, Meichenbaum DH, Genost M. Pain and behavioral medicine: a cognitive behavioral perspective. New York: Guilford, 1983.
60. Ahles T, Blanchard E, Ruckdeschel J. The multidimensional nature of cancer related pain. Pain 1983;17:277-288.
61. Fordyce W. Learning processes in pain. In: Sternbach R, ed. The psychology of pain. New York: Raven, 1978.
62. Gamsa A. The role of psychological factors in chronic pain. I. A half century of study. Pain 1994; 57:5-16, 17-30.
63. Pilowski I. Patterns of illness behavior in patients with intractable pain. J Psychosom Res 1975;19:279-287.
64. Johanson C, Schuster C. Animal models of drug self-administration. In: Mello N, ed. Advances in substance abuse research. Greenwich, CT: JAI, 1981:219-297.
65. Koob G, Bloom F. Cellular and molecular mechanisms of drug dependence. Science 1988; 242:715-723.
66. Gardner E. Brain reward mechanisms. In: Lowinson J, Pruiz, Millman R, eds. Substance abuse: a comprehensive text. Baltimore: Williams and Wilkens, 1992:70-99.
67. Robins L. The Vietnam drug user returns: final report. Washington, DC: Government Printing Office, 1974.
68. Morse RM, Flavin DK. The definition of alcoholism. JAMA 1992;268:1012-1014.
69. Weissman DE, Haddox JD. Opioid pseudo-addiction: an iatrogenic syndrome. Pain 1989;36: 363-366.
70. Savage S. Pain treatment in the addicted patient. Drug Ther Bull 1994 (June).
71. Wesson DR, Smith DE. Prescription drug abuse: patient, physician and cultural responsibilities. West J Med 1990;152:613-616.
72. McCaffery M, Vourakis C. Assessment and relief of pain in chemically dependent patients. Orthop Nurs 1992;11:13-27.
73. Wesson DR, Ling W, Smith DE. Prescription opioids for the treatment of pain in patients with addictive disease. J Pain Symptom Manage 1993;8: 289-296.